After finding changes in integrin and cadherin expression in plasma-treated pancreatic cancer cell lines, and identifying changes in viability and morphology of three-dimensional tumor spheroids, the next step was to analyze cells detached from solid spheroids as a measure to investigate the potential promotion of metastasis with plasma treatment. The gene discussed is CDH17; the disease is familial pancreatic carcinoma.